Skip to main content
. Author manuscript; available in PMC: 2019 Jan 4.
Published in final edited form as: J Alzheimers Dis. 2018;61(1):103–111. doi: 10.3233/JAD-170604

Table 2.

Comparison between groups with AD and non-AD in FDG-PET analysis. Only patients with agreement between visual and semi-quantitative analysis are included

AD Non-AD U-Mann Whitney (p-value)
Age 72.57 ± 8.29 70.39 ± 9.13 139.0 (0.490)
Years of education 11.64 ± 5.59 12.04 ± 4.39 156.0 (0.874)
FR1-FCSRT
 Raw 3.00 ± 2.18 4.43 ± 3.04 118.0 (0.175)
 Scaled 6.86 ± 3.13 8.83 ± 3.92 113 (0.131)
TR-FCSRT
 Raw 21.43 ± 11.84 28.04 ± 10.89 111.5 (0.121)
 Scaled 4.29 ± 2.46 6.00 ± 3.35 113.5 (0.131)
TDR-FCSRT
 Raw 5.57 ± 4.51 8.74 ± 4.09 94.0 (0.036)
 Scaled 4.29 ± 5.96 5.96 ± 4.54 134.0 (0.388)
Index of Sensitivity to Cueing (%) 33.87 ± 21.13 44.42 ± 21.44 121.5 (0.216)
FRA1
 Raw 4.86 ± 1.95 6.87 ± 2.75 87.4 (0.020)
 Scaled 5.57 ± 3.00 8.22 ± 4.11 92.0 (0.029)
CRA1
 Raw 6.64 ± 2.34 7.65 ± 3.08 131.0 (0.343)
 Scaled 7.14 ± 2.59 8.00 ± 4.11 145.5 (0.623)
CRA2
 Raw 8.71 ± 2.55 10.04 ± 2.45 5.09 ± 2.42
 Scaled 5.71 ± 3.12 7.48 ± 3.80 115.5 (0.151)
FRB1
 Raw 3.57 ± 1.86 5.09 ± 2.42 96.0 (0.038)
 Scaled 6.36 ± 1.94 8.70 ± 2.38 62.5 (0.002)
CRB1
 Raw 3.57 ± 1.86 5.35 ± 2.79 150.0 (0.727)
 Scaled 7.64 ± 1.49 8.09 ± 3.35 142.5 (0.558)
CRB2
 Raw 6.21 ± 3.06 8.83 ± 2.79 88.0 (0.021)
 Scaled 5.00 ± 2.77 8.09 ± 3.80 80.5 (0.011)
SdFRA
 Raw 2.71 ± 1.89 4.65 ± 2.72 91.5 (0.028)
 Scaled 7.29 ± 2.61 8.70 ± 2.99 110.5 (0.110)
SdCRA
 Raw 5.86 ± 1.91 7.04 ± 2.51 101.5 (0.060)
 Scaled 8.43 ± 2.37 9.43 ± 3.42 111.5 (0.117)
DR
 Raw 6.64 ± 5.42 12.87 ± 6.34 73.0 (0.006)
 Scaled 3.14 ± 2.21 7.17 ± 4.64 72.0 (0.005)
PD 31.54 ± 24.40 10.53 ± 25.36 88.5 (0.022)